Abstract
An attempt was made to induce immune complex vasculitis by horse serum (HS) infusions in piglets, hoping to produce experimental coronary artery lesions that mimic Kawasaki disease. A total of 21 purebred male piglets of 1.5, 2.5, and 3 mo were divided into HS (n = 14) and control, normal saline (NS; n = 7) groups. In seven piglets, 5 mL/kg of HS was infused, then repeated with 10 mL/kg 10 d later. In another seven piglets, 10 mL/kg of HS was infused three times at 5-d intervals. In three piglets in the control group, 5 and 10 mL/kg of NS was infused at 10-d intervals. In another four piglets of the control group, 10 mL/kg of NS was infused three times at 5-d intervals. Two-dimensional echocardiographic examinations for visualization and measurement of the coronary arteries were done before and after infusions at 4- to 5-d interval. Hematology examination showed that white blood cells and platelets decreased, then increased. The animals were killed at 14–60 d after the first infusion of HS or NS, for histopathologic and immunohistochemical studies. All HS groups developed skin rashes and echocardiographic evidence of coronary artery dilation and histopathologic changes of vasculitis. None in the NS group developed vasculitis. The main changes of the coronary vasculitis were intimal proliferation, smooth muscle cell necrosis, and vacuolization changes. Those that received three HS infusions developed more skin rashes than those that received two infusions. It is concluded that piglets may serve as an experimental model for immune complex vasculitis involving the coronary arteries with skin rashes mimicking Kawasaki disease.
Similar content being viewed by others
Main
Kawasaki disease (KD), an acute self-limiting systemic vasculitis of unknown origin, has become a leading cause of acquired heart disease other than rheumatic heart disease in many developed countries (1–3). Coronary artery lesions (CALs) with aneurysmal dilation, thrombosis, and/or stenosis, leading to myocardial infarction and death, have been recognized as the most severe complication (4, 5). Circulating immune complexes (ICs), triggered by infectious agents, bacteria, or viral or other unknown cause, have been detected in the early phase of KD, implicating that immunopathologic mechanisms might be involved in the pathogenesis of vasculitis in KD (6–10). Attempts to produce coronary vasculitis have been made in mice, weanling rabbits, and guinea pigs by injecting infectious agents, foreign proteins, and Lactobacillus casei cell walls (11–15). Coronary arteritis was induced in weanling rabbits by injecting horse serum (HS) (16). Swine is a unique and promising animal for biomedical research, especially in the field of cardiovascular diseases (17, 18). IC coronary vasculitis, however, was never produced in swine. We tried, therefore, to induce coronary vasculitis in piglets, hoping that CAL mimicking KD could be produced. This study was designed to observe the skin and systemic reactions and hematologic changes, measure the coronary artery diameters by echocardiography, and examine the histopathologic and immunochemical changes of the coronary and systemic arteries in 14 piglets after HS infusions and in seven control piglets infused with normal saline (NS). The implications to KD are discussed.
METHODS
Experimental animal.
A total of 21 purebred castrated piglets, weighing 9–39 kg, aged 1.5–3 mo, randomly selected from a certified farm of national nuclear herd of the Animal Technology Institute Taiwan were subjected to this study. They were equivalent to human age of 3 mo to 1 y as per the percentage of maturation and metabolic age chart (19). The design of this study was approved by the Institutional Review Board of the Animal Technology Institute Taiwan, and the care and handling of piglets followed the guidelines of the Animal Protection Law, Council of Agriculture (20). The HS group consisted of 14 piglets, aged 1.5 mo (n = 2), 2.5 mo (n = 10), and 3 mo (n = 2), and the NS group consisted of seven piglets, aged 1.5 mo (n = 1), 2.5 mo (n = 4), and 3 mo (n = 2).
Procedures.
Piglets were anesthetized by ketamine HCL (5–10 mg/kg body weight), azaperone (Stresnil; 8–10 mg/kg i.m.), or thiamylal sodium (Cytosol; 5–8 mg/kg i.v.), alone or in combination. In each of seven piglets, 5 mL (2.6 g protein)/kg of HS (Cat. No. 16270-035, Lot No. 1026238; GIBCO BRL Life Technologies, Gaithersburg, MD, U.S.A.; <5% gamma globulin, virus, and mycoplasma negative) was infused slowly, then another 10 mL (5.2 g protein)/kg of HS was infused 10 d later in the same way. To another seven piglets, 10 mL (5.2 g protein)/kg of HS was infused i.v. three times at 5-d intervals. In three piglets in the control group, 5 mL/kg of NS was administered i.v., then the second dose of 10 mL/kg of NS was infused 10 d later. In another four piglets in the control group, 10 mL/kg of NS was given three times at 5-d intervals. Before and 60 min after the HS or NS infusions, whole blood was sampled from either the jugular or the femoral vein for the measurement of leukocyte, red blood cell, and platelet counts and Hb, cholesterol, alanine aminotransferase, and aspartate aminotransferase levels.
Echocardiography.
Two-dimensional (2-D) echocardiographic examinations were performed using Hewlett Packard Sonos 100. The diameters of the left coronary artery (LCA) and right coronary artery (RCA) were checked and measured at 4- to 5-d intervals before and after the HS or NS infusion. For the comparison study of their diameter changes, measurements of the diameter were taken 5 mm from the orifice of RCA and LCA. All measurements were taken on the modified parasternal long axis and short axis and modified apical four-chamber views in both right and left lateral positions. All piglets were carefully observed before and after infusions until the day of autopsy. Intraobserver and interobserver measurements were tested.
Tissue collection and histochemistry.
Autopsy was performed at 14, 24, 34, 41, or 60 d after the first dose of HS or NS infusion. Gross appearance and histopathology of the LCA, RCA, and left anterior descending and left circumflex coronary arteries and of the myocardium and systemic arteries such as aorta, and subclavian, iliac, and femoral arteries were checked and studied. The liver, kidney, spleen, ear, and skin were also studied. All tissue specimens were perfused and put in 10% phosphate-buffered formaldehyde. All materials were serially sectioned into segments of 2- to 3-mm thickness, and slides were prepared in hematoxylin and eosin stain. Other special stains, such as Masson's trichrome and van Gieson stains for collagen and ground substances and Ver Hoefe stain for internal elastic membrane, were also obtained.
Immunohistochemistry.
After deparaffinization, tissue sections were treated with 0.05% trypsin for 30 min at 37°C. After washing three times in PBS, the sections again were treated with 3% hydrogen peroxide for 10 min at 37°C, and then washed three times in PBS. Nonspecific antibody binding was blocked by incubation with 5% normal goat serum for 20 min at room temperature. The sections were then incubated at 37°C with rabbit anti-human vascular endothelial growth factor (VEGF; diluted 1:100) polyclonal antibody for 1 h (Cat No. 500-P10, Lot No. 099CY10; Petro Tech EC Ltd, Cambridgeshire, UK). The sections were washed three times in PBS and incubated with biotinylated secondary antibody (Vector Laboratories, Burlingame, CA, U.S.A.) for 30 min at 37°C. The sections were then treated with peroxidase conjugated with avidin-biotin complex for 30 min at 37°C. After the last wash in PBS, slides were developed by incubation with diaminobenzidine until color development was seen. The slides were then counterstained with Mayer's hematoxylin and mounted for light microscopy.
Statistical analysis.
Analysis was carried out using the computer statistical package SPSS (version 7.5) for Windows mean values compared test. Results are expressed as mean ± SD. Comparison between HS and NS groups was performed by using paired and two-sample t tests. Significance was assigned at p < 0.05.
RESULTS
Within 30 min after the first, second, and/or third HS infusion, all piglets showed systemic reactions, such as flushing, tachycardia, and chills. In two piglets, respiratory distress developed, and in four piglets, cyanosis was noted. Erythematous rashes appeared during or immediately after the HS infusion, on the legs in nine (64%) of 14 piglets, on the chest in eight (57%) of 14, on the ears in eight (57%) of 14, on the mouth lips and perioral areas in five (35%) of 14, and at the perineal and perianal regions in 12 (86%) of 14, as seen in Table 1 and Figure 1. Piglets aged ≥2.5 mo developed more skin rashes than those that were younger. The rashes faded and disappeared in 6–8 h in the seven piglets that received two infusions and persisted longer, even for 4–5 d, in the seven piglets that received three infusions. None of the NS group showed the skin rashes or systemic reactions.
In the NS group, 2-D echocardiography demonstrated a 12–53% increase of the diameter of coronary arteries (Table 2, Fig. 2). The HS group showed a more significant dilation of the LCA and RCA (Table 2, Fig. 3). The coronary artery dilation was more significant in the group that received three infusions than in the group that received two infusions. Of the 14 piglets in the HS group, eight (57%) showed severe dilation, 100–150%; three (21%) showed moderate dilation, 75–99%; and three (21%) showed mild dilation, 54–74% (Table 3). The coronary artery diameter changes of the NS and HS groups were highly significant (p < 0.001;Table 4). The mean ± 1 SD of intraobserver measurements of the coronary artery diameters was 0.5 ± 0.05 mm and that of interobserver measurements was 0.6 ± 0.08 mm, indicating that the measurements were reproducible.
Hematology pictures showed an abrupt decrease in the white blood cell counts, from an average of 21 ± 8.7 × 103 to 13.3 ± 8.3 × 103/mL, then followed by an increase up to 26.3 ± 9.7 × 103/mL 7–10 d after infusion. The average platelet count decreased from 373.3 ± 123.8 × 103 to 237.1 ± 114.6 × 103/mL and then increased up to 552.1 ± 227.4 × 103. A mild decrease of Hb levels from 9.8 ± 1.6 to 8 ± 0.5 g was also observed. No significant changes were noted in the levels of cholesterol, serum alanine aminotransferase, and aspartate aminotransferase (p ≥ 0.05).
Histopathologic examinations of coronary and systemic arteries of the NS group showed no significant changes (Fig. 4A). In the HS group, there were many changes of varying intensities, such as internal elastic membrane disruption, mild to severe intimal proliferative changes, and subintimal changes, such as coagulation of the cytoplasm, and disorientation, separation, cytolysis, vacuolization, degranulation, collagen deposition, total dissociation, and fibrosis of the smooth muscle cells (Fig. 4B–F, Table 5). Histopathology of the skin biopsy taken from the site of rashes showed perivascular infiltrations (Fig. 4G). Arteritis changes of varying degrees were noted in 100% of left main coronary (LMC) and left anterior descending (LAD) and in 86% of RCA. Arteritis changes of mild degrees, such as disruption of internal elastic membrane, or patchy edematous areas and/or smooth muscle cell proliferation were also noted in systemic arteries with varying percentages: femoral artery, 21%; ascending aorta, 21%; renal, 14%; iliac artery, 14%; subclavian artery, 14%. No significant changes were observed in the carotid and abdominal aorta. Histopathology of other organs showed no significant changes. Immunohistochemical studies by avidin biotin peroxidase staining showed VEGF antigens in the tunica media and intimal regions in four of 10 piglets in which VEGF staining was done (Fig. 5).
DISCUSSION
The pathology of KD has been well studied. The pathogenesis of the lesions, however, remains not well understood. Immunopathologic mechanisms may play an important role in the genesis of vasculitis in KD (6–10). Circulating ICs in patients with early-phase KD have been detected (8, 9). Onouchi et al.(16) reported that HS-induced IC vasculitis in rabbits was very similar to the pathophysiology of CAL in KD. Swine have been used for the study of cardiovascular diseases (17, 18). They are large, omnivorous, and convenient for therapeutic trials (21, 22). Heart and vessels are easier to examine with 2-D echocardiography. The coronary artery system is similar to that of humans and is applicable for interventional cardiology, cardiac xenotransplantation, and even heart-lung transplantation (23, 24). We used the weanling pigs for the experimental animal because of >80% of the patients with KD were infants and children under younger than 5 y. To avoid any infection-related vasculitis, we selected GIBCO BRL Life Technologies horse sera, with documented quality control, electrophoretic profile, stability testing, and microbiologic screening especially for Reo virus (25).
IC coronary vasculitis with or without aneurysm has been elicited by various agents in mice, guinea pigs, and weanling rabbits (11–16). The pathogenesis of vasculitis postulated includes the fixation of compliments by ICs, activation of compliment cascade, and the release of biologically active fragments, notably the anaphylatoxins (C3a and C5a), which increase vascular permeability and yield chemotactic factors for polymorphonuclear leukocytes (26–29). Tissue damage may also be mediated by free radicals produced by activated neutrophils.
After HS infusion, immediate leukopenia followed by leukocytosis we noted in the present study was similar to that reported by Onouchi et al.(16, 30). Immediately after the HS infusion, platelets were also significantly decreased and then increased, likewise in KD, as noted by Levin et al.(31). They found that peak platelet count was significantly correlated with the subsequent development of coronary artery aneurysms. ICs, detected by precipitation with polyethylene glycol, also appeared in the circulation as the platelet count increased. Platelets can be activated by many different stimuli, including contact with subendothelial tissues, ICs that bind to Fc receptors on the platelet, platelet-activating factors released from leukocytes, and several toxins or enzymes released by bacteria and viruses (31, 32). Cochrane et al.(33) studied the role of platelets in a rabbit model of serum sickness vasculitis, which was similar to the vasculitis of KD where coronary arteries were affected. The platelet IC interaction in pathogenesis of KD was also studied (31, 32). Thrombocytosis occurred with a peak usually in the third to fourth week after the onset of KD (34). In our studies, thrombocytosis was the highest 5–7 d after the HS infusion, likewise that found in rabbits by Onouchi et al.(16). Thus, platelets may become hyperaggregable in both acute and convalescent phases of the illness, playing a role, in part, in the pathogenesis of vasculitis in KD (34).
All piglets that received HS infusion in our study developed varying degrees of exanthemas, starting mostly from the perineal regions, then spreading to the trunk, legs, ear, and mouth. The appearance and spreading of the rashes that we observed were somewhat similar to those of KD described by Fritter et al.(35). Indurative edema and peeling of the skin were not observed in our study. Those that received three infusions of HS developed more exanthemas than those that received two infusions, suggesting that prolonged and continuous exposure to the sensitizing agent may lead to excess antigen, the formation of small to intermediate IC aggregates, not easily phagocytosed by the macrophages, circulating widely, tending to deposit in the blood vessel walls. Whereas exposure to the sensitizing antigen is low, larger IC aggregates are formed, easily phagocytosed by the macrophages (26–29).
To the best of our knowledge, 2-D echocardiographic studies on the normal coronary artery diameter and its changes in weanling piglets have never been reported. We interpreted the coronary artery dimension as abnormal when the increase was >12–53% of the baseline diameter that we observed in the control group (Table 3). Our study showed that coronary artery dilations started to occur 5–10 d after the first infusion of HS. The echocardiographic findings of CALs observed in the piglets of our present study were similar to those observed in our clinical KD patients (36). An altered lipid profile was found in KD by Newberger et al.(37) but was not found in the piglets that we studied. Long-term follow-up studies might be needed to observe the lipid profile abnormalities in piglets.
The histopathologic changes of coronary arteries that we produced in piglets by HS infusions mimic the subacute to chronic phase changes of coronary vasculitis observed in KD patients (38, 39). In all piglets, the changes were most significant in the tunica media, likewise the initial changes of coronary arteries in KD occurring in the tunica media at approximately 7–9 d after the onset of the disease, as reported by Naoe (40). VEGF is one of the most important growth and survival factors for endothelium. It induces angiogenesis and endothelial cell proliferation and plays an important role in regulating vasculogenesis by increasing vascular permeability and vasodilation, partly through stimulation of nitric oxide synthase in endothelial cells (41, 42). VEGF can also stimulate cell migration and inhibit apoptosis. In humans, VEGF was significantly elevated during the acute phase of KD (41). The presence of VEGF antigen that we observed in the tunica media and intimal regions of the piglets' coronary arteries is an indirect evidence of vasculitis produced by HS infusion (42).
Our study revealed that induction of IC coronary arteritis was possible in piglets of 9–39 kg, equivalent to infants aged 3–12 mo. Type III hypersensitivity reaction, induced by antigen-antibody complexes, produced tissue damages as a result of their capacity in activating a variety of serum mediators, principally the compliment system. Both ICs and platelets may have some roles in the pathogenesis of vasculitis. Different measuring methods yield varying ICs of different sizes and compositions at different times in the course of a given disease (43). ICs were also identified in the autopsy specimens of KD, suggesting that ICs might have played a role in producing the coronary artery changes in KD patients (43). ICs were also identified in the circulation of the experimental rabbit models with serum sickness (29). The present study documented that systemic type III hypersensitivity reactions to HS infusions in piglets produced vasculitis mimicking KD. We suggest, therefore, that such a similar mechanism may be involved in the pathogenesis of coronary arteritis in KD.
Until now different kinds of protein, such as HS, infectious agents, and bacterial walls, have been used to produce the experimental coronary arteritis (11–16). Of those models, the present animal model is the first experimental model that comes close, mimicking most the clinical pictures of KD, but cannot be called a complete model. It is hoped that a complete KD experimental model will be developed in the future.
CONCLUSION
In conclusion, using the HS as the triggering agent, we succeeded in producing coronary artery vasculitis in 14 piglets. CALs were detected by 2-D echocardiography and were proved by histopathology. The rashes, hematoserologic changes, and CALs were similar to KD. We postulate that IC-mediated mechanisms may play a role in the pathogenesis of CALs in KD. A swine model of HS-induced coronary arteritis may serve as an experimental model of KD and may also serve as a model for therapeutic trials and prevention of coronary artery disease in KD.
Abbreviations
- CAL:
-
coronary artery lesion
- HS:
-
horse serum
- IC:
-
immune complex
- KD:
-
Kawasaki disease
- LCA:
-
left coronary artery
- NS:
-
normal saline
- RCA:
-
right coronary artery
- VEGF:
-
vascular endothelial growth factor
References
Kawasaki T 1967 Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: clinical observations of 50 cases. Arerugi Jpn J Allergol 16: 178–222
Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagwa H 1974 A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54: 271–276
Shulman ST, Delnocencio J, Hirsch R 1995 Kawasaki disease. Pediatr Clin North Am 42: 1205–1222
Fujiwara T, Fujiwara H, Ueda T, Nishioka K, Hamashima Y 1986 Comparison of macroscopic, postmortem, angiographic findings of coronary aneurysms in children with Kawasaki disease. Am J Cardiol 57: 761–764
Naoe S, Shibuya K, Takahashi K, Wakayama M, Masuda H, Tanaka M 1991 Pathological observations concerning the cardiovascular lesions in Kawasaki disease. Cardiol Young 1: 212–220
Fossard C, Thompson RA 1977 Mucocutaneous lymph-node syndrome (Kawasaki disease): probable soluble complex disorder. BMJ 1: 883–884
Weindling AM, Levinsky RJ, Marshall WC, Hood J 1979 Circulating immune complexes in mucocutaneous lymph-node syndrome (Kawasaki disease). Arch Dis Child 54: 241–242
Furuse A, Matsuda I 1983 Circulating immune complex in the mucocutaneous lymph node syndrome. Eur J Pediatr 141: 50–51
Mason WH, Jordan SC, Sakai R, Takahashi M, Bernstein B 1985 Circulating immune complexes in Kawasaki syndrome. Pediatr Infect Dis 4: 48–51
Li CR, Yang XQ, Shen J, Li YB, Jiang LP 1990 Immunoglobulin G subclasses in serum and circulating immune complexes in patients with Kawasaki syndrome. Pediatr Infect Dis 9: 544–547
Keren G, Wolman M 1984 Can Pseudomonas infection in experimental animals mimic Kawasaki disease?. J Infect 9: 22–29
Murata H 1970 Experimental Candida-induced arteritis in mice: relation to arteritis in the mucocutaneous lymph node syndrome. Microbiol Immunol 23: 825–831
Cromartie WJ, Craddock JG 1966 Rheumatic-like cardiac lesion in mice. Science 154: 283–284
Lehman TJA, Walkwer SM, Mahanovsky V, Mc Curdy D 1985 Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum 28: 652–659
Rich AR, Gregory JE 1943 The experimental demonstration that polyarteritis nodosa is manifestation of hypersensitivity. Johns Hopkins Med J 72: 63–83
Onouchi Z, Ikuta K, Nagamatsu K, Tamiya H, Sakakibara Y, Ando M 1995 Coronary artery aneurysms develop in weanling rabbits with serum sickness but not in mature rabbits: an experimental model for Kawasaki disease in humans. J Vasc Dis 46: 679–686
McKenzie KE 1995 Swine as a model in cardiovascular research. In: Tumbleson ME, Schook LB (eds) Advances in Swine Biomedical Research,Vol 1. Plenum Press, New York, pp 7–15.
Brown DR, Terris JM 1995 Swine in physiological and pathophysiological research. In: Tumbleson ME, Schook LB (eds) Advances in Swine Biomedical Research,Vol 1. Plenum Press, New York, pp 5–6.
Kirkwood JK, Webster AJF 1984 Energy-budget strategies for growth in mammals and birds. Anim Prod 38: 147–155
Animal Protection Law 1998 Council of Agriculture Executive Yuan, Taiwan, amended, 2001. Hua-Zong, Yi-Tzi, Taipei, Taiwan. Available at: www.coa.gov.tw/coa/eng/index.html
Lee KT 1986 Swine as animal models in cardiovascular research. In: Tumbleson ME (ed) Swine in Biomedical Research, Vol 3. Plenum Press, New York, pp 1481–1496.
Hall TS, Rosengrad BR, Stone CD, Baumgartner WA, Reitz BA 1990 Pig models for heart-lung transplantation research. In: Proceedings of the Second International Symposium on Pig Model for Biomedical Research; Nov 29–Dec 2, 1990; Academia Sinica, Taipei, pp 55–65.
Sachs DH, Leight G, Cone J, Schwartz S, Stuart L, Rosenberg S 1976 Transplantation in miniature swine, fixation of the major histocompatibility complex. Transplantation 22: 559–567
Allan JS, Rose JK, Choo JK, Arn JS, Vesga L, Mawulawde JK, Allison K, Madsen JC 1999 Morphometric analysis to predict appropriate donor size for swine-to-human cardiac xenotransplantation. Transplant Proc 31: 975–977
Note for guidance on quality of biotechnological products 1996 Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. Monograph of Horse Serum. CPMP/ICH/295/95
Janeway CA, Travers P, Walport M, Capra JD 1999 Immune Biology: Immune System in Health and Disease, 4th Ed. Garland Publishing, New York, pp 479–481.
Price SA, Wilson LM 1997 Pathophysiology: Clinical Concepts of Disease Response of the Body to Immunologic Challenge. Mosby Co, St. Louis, pp 79–80.
Woolf N 1998 Pathology: Basic and Systemic. WB Saunders Co, London, pp 129–131.
Johnson KJ, Chensue SW, Kunkel LS, Ward PA 1988 Immunopathology. In: Rubin E, Farber JL (eds) Pathology. J. B. Lippincott Co, Philadelphia, pp 110–113.
Onouchi Z, Tomizawa M, Goto M, Nakata K, Fukuda M, Goto M 1975 Cardiac involvement and prognosis in acute mucocutaneous lymph node syndrome. Chest 68: 297–301
Levin M, Holland PC, Nokes TJC, Novelli V, Mola M, Levinsky RJ, Dillon MJ, Barrat TM, Marshall WC 1985 Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis. BMJ 290: 1456–1460
Shirahata A, Nakamura I, Asakura A 1983 Studies on blood coagulation and antithrombotic therapy in Kawasaki disease. Acta Paediatr Jpn 25: 104–115
Cochrane CG 1971 Mechanisms involved in the deposition of immune complex in tissues. J Exp Med 134: 755–758
Yamada K, Shirahata A, Shinakai A, Meguro T 1977 Haematological studies on acute febrile mucocutaneous lymph node syndrome with special reference to the platelet-thrombus formation and etiology of MCLNS. Acta Paediatr Jpn 81: 1263–1267
Fritter BS, Lucky AW 1988 The perineal eruption of Kawasaki syndrome. Arch Dermatol 124: 1805–1810
Yang CC, Lue HC, Wang JK, Wu MH, Wu YN 1990 A detection and follow up study of coronary arterial lesions in Kawasaki disease by two-dimensional echocardiography. Acta Cardiol Sin 6: 262–275
Newburger JW, Burns JC, Beiser AS, Localzo J 1991 Altered lipid profile after Kawasaki syndrome. Circulation 84: 625–631
Tanaka N, Naoe S, Masuda H, Tesuo U 1986 Pathological study of sequelae of Kawasaki disease (MCLS) with special reference to the heart and coronary arterial lesions. Acta Pathol Jpn 36: 1513–1527
Suzuki A, Tomita SM, Komatsu K 2000 Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease; immunohistochemistry study. Circulation 101: 2935–2941
Naoe S 2000 Pathology of coronary aneurysms in the young. Abstract (CS12) presented at the 10th Asian Congress of Pediatrics; March 26–30, 2000; Taipei, Taiwan
Hausner EA, Orsini JA, Foster LL 1999 Vascular endothelial growth factor in porcine coronary arteries following balloon angioplasty. J Invest Surg 12: 15–23
Terai M, Yasukawa K, Narumoto S, Taeno S, Oana S, Kohno Y 1999 Vascular endothelial growth factor in acute Kawasaki disease. Am J Cardiol 83: 337–339
Patchman LM, Herold BC, Davis AT, Hang LM, Schaller JG, Beckwith B 1987 Immune complexes in Kawasaki syndrome: a review. Prog Clin Biol Res 250: 193–207
Acknowledgements
We thank Dr. J.H. Lin, Dr. S.W. How, and Dr. C.H. Hsiao for pathology discussions; Dr. B.S. Tzang, P.H. Lin, and L. Ho for expert technical assistance and autopsy; Dr. M.T. Chiou for immunohistochemical studies; Dr. W.Y. Shau (statistical advice); and Dr. J.K. Wang, Dr. T.J. Lehman, Dr. Z. Onouchi, and Dr. T.S. Yang (inspiration, critical suggestions, controversial thoughts, and advice).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by Animal Technology Institute Taiwan (National Science Council grant no. 89-2313-8-059-036), Cardiac Children's Foundation, and Min-Sheng General Hospital.
Rights and permissions
About this article
Cite this article
Philip, S., Lee, WC., Liu, SK. et al. A Swine Model of Horse Serum-Induced Coronary Vasculitis: An Implication for Kawasaki Disease. Pediatr Res 55, 211–219 (2004). https://doi.org/10.1203/01.PDR.0000104151.26375.E5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/01.PDR.0000104151.26375.E5
This article is cited by
-
Recent Advances in Kawasaki Disease – Proceedings of the 3rd Kawasaki Disease Summit, Chandigarh, 2014
The Indian Journal of Pediatrics (2016)
-
Animal Models of Vasculitides
Clinical Reviews in Allergy & Immunology (2008)
-
Polymorphism of Fcγ RIIa May Affect the Efficacy of γ-Globulin Therapy in Kawasaki Disease
Journal of Clinical Immunology (2005)